Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Net Income towards Common Stockholders (2020 - 2025)

Medicale (MCLE) has disclosed Net Income towards Common Stockholders for 5 consecutive years, with -$8654.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders changed N/A year-over-year to -$8654.0, compared with a TTM value of -$33652.0 through Sep 2025, changed N/A, and an annual FY2025 reading of -$33652.0, changed N/A over the prior year.
  • Net Income towards Common Stockholders was -$8654.0 for Q3 2025 at Medicale, down from -$3575.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $455.0 in Q4 2022 and bottomed at -$14995.0 in Q4 2024.
  • Average Net Income towards Common Stockholders over 4 years is -$4686.2, with a median of -$5001.5 recorded in 2025.
  • Peak annual rise in Net Income towards Common Stockholders hit 175.83% in 2022, while the deepest fall reached 90.84% in 2022.
  • Year by year, Net Income towards Common Stockholders stood at -$600.0 in 2021, then surged by 175.83% to $455.0 in 2022, then plummeted by 3395.6% to -$14995.0 in 2024, then soared by 42.29% to -$8654.0 in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for MCLE at -$8654.0 in Q3 2025, -$3575.0 in Q2 2025, and -$6428.0 in Q1 2025.